The warning affects all treatments containing GLP-1 receptor agonists, including semaglutide ( Ozempic, Wegovy, Rybelsus ), ...

Kennedy Jr. has his way, get ready for even more anti-pharma rhetoric and potential instability at the Food and Drug ...

The FDA is warning that patients taking GLP-1s may be at a higher risk of inhaling fluid into their lungs while under ...

Nov. 6, 2024 – The FDA has updated the labels for all GLP-1 weight loss drugs with a warning about pulmonary aspiration ...

The unlisted ingredients can cause "life threatening" drops in blood pressure when used in combination with other prescription drugs.

Organon (OGN) stock on watch as FDA delays a potential label expansion for its VTAMA cream, impacting 2025 EBITDA margin and ...

Subsidies of up to NT$100,000 are also available for chain stores to reimburse the cost of printing new labels and materials, it said. Businesses for which at least five stores display proper labeling ...

Recently the U.S. Food and Drug Administration (FDA) issued updated safety warnings for all glucagon-like peptide 1 receptor ...

The Food and Drug Administration has updated labels for popular weight loss drugs like Ozempic and Wegovy. NFL News: ...

On November 5, the US Food and Drug Administration (FDA) updated the labels for all glucagon-like peptide 1 receptor agonists (GLP-1 RA) with a warning about pulmonary aspiration during general ...

The U.S. Food and Drug Administration's recall concerns two butter products produced by Continental Dairy ...